Vito Quaranta

Vanderbilt University honored 27 retiring faculty members and one dean for their years of service by bestowing upon them the title of emerita or emeritus faculty during Vanderbilt’s Commencement ceremony on May 10 at GEODIS Park. Read More

MuSyC is a technique to help researchers devise new combinations of drugs. An open-source analysis tool, it holds the promise speed such discoveries around the world. Read More

The Center for Technology Transfer and Commercialization continued to play a pivotal role in translating the research findings of Vanderbilt faculty into products and companies in 2020 that have the potential to transform many aspects of life, from disease prevention to quality of life-enhancing products. Read More

Drug-tolerant persister cells–those that survive cancer treatment–found to rely on similar survival mechanisms across cancers, in a groundbreaking study led by Vanderbilt researchers. Read More

Drug combinations used for the treatment of non-small-cell lung cancer (NSCLC) and melanoma aren’t as effective as they could be. Oncologists haven’t had the right tools to predict drug interactions, other than in costly clinical trials. That could change with a new algorithm developed by a cross-disciplinary Vanderbilt University team… Read More

A five-year National Cancer Institute grant will fund an interdisciplinary research center for the study of small cell lung cancer, a highly aggressive, incurable form of the disease. Read More

Vanderbilt investigators have discovered that cancer treatment induces an “idling” state for cells, which could promote resistance to treatment. Read More

With the help of a drug formerly used to treat HIV/AIDS, researchers at Vanderbilt University Medical Center (VUMC) have found a way to make melanoma cells more vulnerable to targeted anti-cancer therapy. Read More

The primary method used to test compounds for anti-cancer activity in cells is flawed, Vanderbilt University researchers reported May 2 in Nature Methods. Read More

Ten members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science. Read More

A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments. Read More

The protein matriptase "cuts" a key component of the prostate tissue barrier and may be involved in prostrate cancer progression, new research finds. Read More